Close menu

November 19th, 2021 | 13:13 CET

Sativa Wellness Group, Aurora Cannabis, TUI - Rising consumer spending on wellness and travel

  • Cannabis
Photo credits:

According to Statista, the health and wellness market is worth around EUR 105 billion. More than USD 900 billion is spent annually worldwide on beauty and antiaging alone. Spending on travel is also increasing significantly after a sharp drop in the wake of the Corona pandemic. Reason enough to take a look at three stocks of industry representatives. Who is making the running?

time to read: 4 minutes | Author: Carsten Mainitz

Table of contents:

    Sativa Wellness Group - Another step closer to its lofty goals

    The legalization of cannabis has created an industry worth billions. Sativa Wellness wants to cut itself a piece of this pie and set itself very lofty goals in the process. The Company intends to become one of the leading manufacturers and high-quality distributors of CBD and wellness products and services in Europe. Elemental to this is the implementation of full vertical integration of supply chains and the expansion of the distribution network.

    Currently, Sativa is focused on the UK, operating in three business areas. CBD products for consumers are offered under the Goodbody Botanicals brand. With its subsidiary PhytoVista, the Group operates CBD and hemp testing laboratories. Goodbody Wellness clinics provide testing services - including COVID testing - for clinics, as well as direct-to-consumer and direct-to-business services via a telemedicine consultation service. Sativa now has more than 80 clinics in operation. Most recently, it announced a distribution partnership in Germany.

    Recently, the Company announced a partnership with Superdrug Stores to offer a full range of blood testing services. The agreement includes 40 Superdrug locations where trained nurses draw blood for a range of tests. Customers order the test they want on the Goodbody Clinic website. They can then choose to have a personal blood test, select a Superdrug clinic or use one of the participating Goodbody stores to collect the blood. Commenting on the new developments, Geremy Thomas, Executive Chairman, said, "Our Goodbody clinics' partnership with Superdrug for wellness blood testing expands the options for customers. It allows them to have the test they want at a location that is convenient for them and allows them to take control of their wellness."

    The Company continues to exceed the goals it has set for itself, reflected in its most recently released quarterly data. Over the same quarter last year, third-quarter revenue was up 977% to CAD 8.6 million, nearly a tenfold increase. Gross profit increased to CAD 4.59 million, with an even slightly higher rate of growth. The gross profit margin was reported at the previous year's level of 53%. After a loss of CAD 1.19 million, the Company managed to be in the black with a net profit of CAD 14,000 in Q3. The Company has a moderate valuation level with a stock market value of around CAD 26 million.

    TUI - The USA opens its doors again for travelers

    For a few days now, it has been possible for EU citizens to enter the USA again, provided they have been fully vaccinated and have tested negative for the coronavirus. The German Lufthansa stated that there is great demand, and it expects a load factor on the pre-crisis level in the coming weeks.

    Christmas shopping in New York or a beach vacation in Florida attracts many tourists to the United States. "We see a significant catch-up effect in travel, both in short-term bookings, especially by couples and small groups for November and December, and in long-term trips by families during the Easter and summer vacations," explained newly appointed TUI Germany CEO, Stefan Baumert.

    This news has completely bypassed the share. In the first quarter, the share certificates still cost around EUR 4.50 at times, and now EUR 2 less is being called on the stock exchange. That means that the Group is still valued at EUR 2.8 billion. The average analyst estimates for 2021 are sales of EUR 5.6 billion and a loss of EUR 2.2 billion. The turnaround is expected to occur in 2022, when experts anticipate sales of EUR 16 billion and a return to the black, with profits of EUR 234 million. Overall, analysts currently rate the stock as "hold".

    Aurora Cannabis Inc - Can the world's number two finally take off thanks to a reduced quarterly loss?

    Canadian Company Aurora Cannabis, based in Edmonton, Alberta, is the world's second-largest cannabis producer. With a market capitalization of around CAD 1.9 billion, the Company has an 8.74% stake in the Prime Alternative Harvest Index, just behind market leader Tilray (8.96%). The producer of medical and consumer cannabis products, which has been in the red for years, has recently come under pressure on the stock market, like other cannabis stocks. But there is light at the end of the tunnel.

    Aurora managed to narrow its loss to CAD -0.06 in the past quarter, down from CAD -0.90 in the corresponding quarter last year. Analysts had forecast a loss of CAD -0.256. After the announcement of the figures, the share price increased by up to 7%. One reason for the friendly attitude of investors is likely to be rooted in the expectation that there could soon be federal marijuana legislation in the US, which could allow companies like Aurora Cannabis to access regular services, especially in the banking sector.

    In anticipation of an imminent solution in the US, Aurora had already acquired Reliva LLC. in 2020, one of the largest US producers of CBD products. It is also in line with the strategy of the new CEO Miguel Martin, in office since September last year, to focus on profitable markets and niches in the future. This focus definitely makes sense.

    All three of the stocks mentioned above are benefiting from rising consumer spending in the fields of wellness, health and travel. TUI is an attractive turnaround story at the current share price level. Sativa Wellness Group offers an exciting investment story at a moderate valuation. If Aurora manages to reduce its loss further, the stock is also worth a look.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author

    Related comments:

    Commented by Stefan Feulner on September 22nd, 2022 | 11:32 CEST

    BioNTech, XPhyto, Valneva - It is over!

    • Biotechnology
    • Covid19
    • Cannabis

    In an interview with the television station "CBS", the most powerful man in the world, US President Joe Biden, declared the pandemic over. While people in Germany have to wear face masks to the Oktoberfest in local and long-distance transport and then blare the latest hits from Mallorca in the marquee, without masks, of course, outside the former growth engine of Europe, relaxation seems to be setting in regarding COVID-19. A blow to the global vaccine industry! Meanwhile, a new market is growing unnoticed in the healthcare industry that could trigger a lasting trend in the near future.


    Commented by Nico Popp on September 1st, 2022 | 14:05 CEST

    New trending stock in the wings? Plug Power, Cardiol Therapeutics, BioNTech

    • Biotechnology
    • Cannabis
    • Hydrogen

    The markets want to go up! Last Friday, the Fed shock worried the markets, but today, even speculative stocks are picking up again. Especially stocks that were long considered deregistered can quickly develop potential. One example is Plug Power. Here, new demand in the wake of high energy prices meets good products. We explain the secret to the success of comeback stocks, using Plug Power as an example, and highlight new opportunities.


    Commented by Carsten Mainitz on February 4th, 2022 | 12:22 CET

    Novavax, Cardiol, MorphoSys - Here's the second wave of Corona vaccine plays!

    • Cannabis

    The number of new Corona infections reported to the Robert Koch Institute (RKI) within one day has reached an all-time high. 236,120 additional cases were recorded, bringing the number of people in Germany who were confirmed to be infected with Sars-CoV-2 to 10.4 million. However, the number of unreported cases is significantly higher. Vaccine manufacturers from the early days have been able to clear the table in recent months, and now new companies such as Novavax and Valneva are entering the scene. But not all innovative approaches to fighting Corona are on the radar of investors. These are perfect conditions for a second share price wave.